TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 26 of 158 • 3,933 articles
Datavault AI Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin
GlobeNewswire Inc. • Globe Newswire
Datavault AI Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin

11/21/2025 03:56 PM • Datavault AI will distribute Dream Bowl 2026 Meme Coins to eligible equity holders of Datavault AI and Scilex, with record dates set for November 25, 2025, subject to Board of Directors' discretion.

DVLT - Company is executing a planned token distribution with standard procedural details and cautionary forward-looking statements
#meme coins #distribution #tokenization #digital wallet #equity holders
Read More
Bulls, Bands, and Barrels Unveils First Half of 2026 With Its Biggest Lineup Yet! Jon Pardi, Ella Langley, BigXthaPlug, Gavin Adcock, Hudson Westbrook, Sam Barber, Dylan Gossett, & More
GlobeNewswire Inc. • Ellen Newberg
Bulls, Bands, and Barrels Unveils First Half of 2026 With Its Biggest Lineup Yet! Jon Pardi, Ella Langley, BigXthaPlug, Gavin Adcock, Hudson Westbrook, Sam Barber, Dylan Gossett, & More

11/21/2025 03:00 PM • Bulls, Bands, and Barrels (BBB) announces its 2026 tour featuring country music artists and western sports entertainment, launching January 10th in Evansville, Indiana with performances across multiple U.S. cities.

COF - Mentioned in context of portfolio conversion that may temporarily impact Mastercard's volume growth
BOOT - Mentioned as a national sponsor of the tour with no additional context provided
#country music #bull riding #barrel racing #western sports #tour #live entertainment
Read More
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
GlobeNewswire Inc. • Rosen Law Firm
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

11/21/2025 02:56 PM • Rosen Law Firm is pursuing a securities class action lawsuit against Inspire Medical Systems for allegedly misrepresenting market demand and launch details of their Inspire V sleep apnea device during the period of August 6, 2024 to August 4, 2025.

COFpI - Mentioned in context of portfolio conversion that may temporarily impact Mastercard's volume growth
INSP - The lawsuit alleges the company issued false and misleading statements about their device's market demand and launch preparedness, suggesting potential intentional misrepresentation of company performance
#securities class action #sleep apnea device #investor lawsuit #market misrepresentation
Read More
CarMax, Inc. (KMX) Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline, Class Action Pending -- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
CarMax, Inc. (KMX) Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline, Class Action Pending -- Hagens Berman

11/21/2025 02:53 PM • CarMax experienced significant stock decline after firing CEO Bill Nash and announcing an expected 8-12% comparable store used unit sales decline in Q3 2026, following poor Q2 financial results.

COFpJ - Mentioned in context of portfolio conversion that may temporarily impact Mastercard's volume growth
KMX - Stock dropped 24% after CEO firing, reported declining sales, poor financial performance, potential securities fraud allegations, and negative analyst commentary suggesting deeper business issues
#CarMax #stock decline #CEO termination #sales decline #securities class action
Read More
MoonLake Immunotherapeutics’ (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
MoonLake Immunotherapeutics’ (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman

11/21/2025 02:52 PM • MoonLake Immunotherapeutics experienced a nearly 90% stock price collapse after disappointing Phase 3 trial results for its lead drug sonelokimab, leading to a securities fraud class action lawsuit alleging misleading statements about the drug's clinical prospects.

COFpK - Mentioned in context of portfolio conversion that may temporarily impact Mastercard's volume growth
MLTX - Stock price dropped 90%, failed Phase 3 trial, facing securities fraud lawsuit, drug candidate showed lower efficacy than competitor
#biotechnology #clinical trials #securities fraud #drug development #hidradenitis suppurativa
Read More
Dime Awards Grant to Long Island Cares
GlobeNewswire Inc. • Avinash Reddy
Dime Awards Grant to Long Island Cares

11/21/2025 02:48 PM • Dime Community Bancshares awarded a grant to Long Island Cares to support food-insecure populations in Nassau and Suffolk counties, demonstrating community commitment.

COFpL - Mentioned in context of portfolio conversion that may temporarily impact Mastercard's volume growth
DCOM - Proactively supporting local community through charitable grant to address food insecurity
#grant #food insecurity #community support #Long Island
Read More
GSCAI Announces the Launch of Its AI-Powered Market Strategy System for Digital Asset Investors
GlobeNewswire Inc. • Globe Newswire
GSCAI Announces the Launch of Its AI-Powered Market Strategy System for Digital Asset Investors

11/21/2025 02:38 PM • GSCAI introduces a new cloud computing platform powered by renewable energy, offering AI-driven computing services with global data centers and high-efficiency GPU clusters to help investors navigate digital asset markets.

COFpN - Mentioned in context of portfolio conversion that may temporarily impact Mastercard's volume growth
NVDA - Mentioned as a GPU technology provider without specific context of performance or impact
#cloud computing #AI #renewable energy #digital assets #GPU clusters
Read More
Why AI Stock Ceva Was Sliding Hard This Week
The Motley Fool • Eric Volkman
Why AI Stock Ceva Was Sliding Hard This Week

11/21/2025 02:33 PM • Ceva announced a secondary stock offering of 3 million shares at $19.50 per share, causing its stock price to drop over 22% for the week due to potential shareholder dilution.

CEVA - Stock price dropped significantly after announcing a new share issuance that could dilute existing shareholders' value, with potential concerns about the company's financial strategy
#AI #stock offering #capital raise #shareholder dilution
Read More
HII Completes Acceptance Trials for Destroyer Ted Stevens (DDG 128)
GlobeNewswire Inc. • Hii
HII Completes Acceptance Trials for Destroyer Ted Stevens (DDG 128)

11/21/2025 02:00 PM • Ingalls Shipbuilding successfully completed sea trials for the Arleigh Burke-class guided missile destroyer Ted Stevens (DDG 128), demonstrating mission capabilities and preparing for U.S. Navy delivery.

HII - Successfully completed sea trials, highlighted team's skill and achievement in building advanced warships, and demonstrated continued progress in naval shipbuilding
#destroyer #sea trials #naval shipbuilding #Arleigh Burke-class #U.S. Navy
Read More
Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure -- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure -- Hagens Berman

11/21/2025 01:55 PM • Primo Brands Corporation faces a securities class action lawsuit alleging misleading statements about its merger with BlueTriton Brands, with CEO Robbert Rietbroek departing after revealing significant integration challenges and reduced revenue forecasts.

PRMB - Company experienced significant merger integration problems, reduced revenue forecasts, CEO departure, and stock price dropped 36% after revealing operational disruptions
#securities lawsuit #merger #integration #revenue forecast #CEO departure
Read More
Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
GlobeNewswire Inc. • Glancy Prongay & Murray Llp
Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

11/21/2025 01:54 PM • Synopsys faces a class action lawsuit alleging misleading statements about its business performance, with shareholders urged to file a lead plaintiff motion by December 30, 2025, following a significant stock price drop after reporting underperforming IP business results.

AAPL - Traded flat with mixed signals of iPhone 17 optimism and weaker demand in China
SNPS - Company reported a 43% year-over-year decline in net income, missed revenue guidance, experienced a 7.7% decline in Design IP segment revenues, and saw its stock price drop 35.8% after revealing business underperformance
#securities fraud #class action #investor lawsuit #financial disclosure
Read More
DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions
GlobeNewswire Inc. • Law Offices Of Howard G. Smith
DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

11/21/2025 01:52 PM • Law Offices of Howard G. Smith alerts investors about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations across various industries.

NVDA - Rose almost 1% after announcing plans to supply over 260,000 AI chips to South Korean companies
FUN - Allegations of chronic underinvestment in parks, deferring maintenance, and making misleading statements about operational capabilities and financial prospects
#securities fraud #class action #shareholder lawsuit #investor protection
Read More
3 Forces That Should Drive Investments in 2026
Investing.com • Dave Kovaleski
3 Forces That Should Drive Investments in 2026

11/21/2025 01:45 PM • Goldman Sachs predicts the S&P 500 will reach 7,600 in 2026, driven by potential rate cuts, AI investments, and increased mergers and acquisitions activity.

FSLR - Topped S&P 500 leaderboard with stronger-than-expected earnings and raised guidance
NVDA - Expected to continue strong AI capital expenditure investments
#rate cuts #artificial intelligence #mergers and acquisitions #investment outlook
Read More
US Equities Show Signs of Stabilizing While Yield Compression Supports Risk
Investing.com • Itai Smidt
US Equities Show Signs of Stabilizing While Yield Compression Supports Risk

11/21/2025 01:37 PM • US markets showed signs of recovery after a volatile week, with dovish Federal Reserve signals and expectations of a December rate cut supporting investor sentiment. Tech stocks experienced a pullback, while healthcare and retail sectors demonstrated resilience.

NFLX - Climbed 3.5% and announced a 10-for-1 stock split
NVDA - Despite strong Q3 results, stock dropped 5.5% as investors questioned AI capital expenditure sustainability
#Federal Reserve #rate cut #AI stocks #market correction #healthcare #retail
Read More
Enrollment Drop, Compliance Allegations Fuel Stride (LRN) Shareholder Lawsuit-- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
Enrollment Drop, Compliance Allegations Fuel Stride (LRN) Shareholder Lawsuit-- Hagens Berman

11/21/2025 01:36 PM • Stride Inc., an online educational services provider, faces a securities class action lawsuit alleging fraudulent practices including inflated enrollment numbers, non-compliance with educational regulations, and misleading investors about company performance.

LRN - Accused of multiple unethical practices including inflating student enrollments, ignoring compliance requirements, suppressing whistleblowers, and misrepresenting company performance. Stock price declined significantly after revelations of operational challenges and potential fraud.
#EdTech #securities fraud #enrollment manipulation #investor lawsuit
Read More
Smithfield Foods Donates 32,000 Pounds of Protein to Hampton Roads Foodbanks at the Mayflower Marathon
GlobeNewswire Inc. • Ray Atkinson
Smithfield Foods Donates 32,000 Pounds of Protein to Hampton Roads Foodbanks at the Mayflower Marathon

11/21/2025 12:49 PM • Smithfield Foods donated 32,000 pounds of protein to the Mayflower Marathon Holiday Food and Fund Drive, supporting the Virginia Peninsula Foodbank and Foodbank of Southeastern Virginia. The donation will provide 128,000 food servings to neighbors experiencing hunger in Southeastern Virginia.

WEN - 5%+ dividend yield, global expansion plans, growing digital sales, potential for margin expansion
SFD - Company demonstrated corporate social responsibility by donating significant protein quantities to local foodbanks and supporting community hunger relief efforts
#food donation #hunger relief #protein #foodbank #holiday drive
Read More
Metal Recycling and Recovery Market Size to Hit USD 957.06 Billion by 2035
GlobeNewswire Inc. • Towards Chemical And Materials
Metal Recycling and Recovery Market Size to Hit USD 957.06 Billion by 2035

11/21/2025 12:47 PM • The global metal recycling market is projected to grow from $571.57 billion in 2025 to $957.06 billion by 2035, driven by sustainability demands, technological advancements, and increasing recycling of critical metals for electric vehicles and renewable energy.

JBLU - Cost-cutting initiatives, positive Q3 unit revenue, new route expansions, and fleet modernization
NUE - North America's largest steel producer using internal scrap recycling, aligned with sustainable manufacturing practices
#metal recycling #circular economy #sustainability #electric vehicles #battery metals
Read More
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward -- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward -- Hagens Berman

11/21/2025 12:46 PM • aTyr Pharma reported a wider-than-expected quarterly loss and is facing a securities class action lawsuit after its Phase 3 clinical trial for Efzofitimod failed to meet primary endpoints, causing an 83% stock price drop.

ATYR - Company experienced significant stock price decline, missed financial estimates, failed clinical trial, and is now facing investor litigation over alleged misleading statements about drug efficacy
#clinical trials #securities litigation #pharmaceutical #drug development #FDA
Read More
BCC Research Launches New Model Context Protocol (MCP) Connections, Unlocking Instant Access to Proprietary Market Data
GlobeNewswire Inc. • Scott Hall, Ryan Brothwell
BCC Research Launches New Model Context Protocol (MCP) Connections, Unlocking Instant Access to Proprietary Market Data

11/21/2025 12:43 PM • BCC Research introduced a new Model Context Protocol (MCP) that enables instant, secure access to market intelligence data through AI-powered servers, allowing businesses to integrate verified research directly into their AI systems.

GOOG - Mentioned as supporting MCP technology without specific details about their implementation
#AI #market intelligence #MCP #data integration #enterprise AI
Read More
Transaction in Own Shares
GlobeNewswire Inc. • Shell Plc
Transaction in Own Shares

11/21/2025 12:37 PM • Shell plc announced its ongoing share buy-back programme, purchasing 749,814 shares on the London Stock Exchange and 748,549 shares on the Amsterdam Stock Exchange, with Merrill Lynch International executing independent trading decisions.

SHEL - The company is executing a routine share buy-back programme as part of standard financial management, with no indication of significant positive or negative market impact
#share buy-back #stock repurchase #market regulations #trading
Read More
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
GlobeNewswire Inc. • Patrick Gaynes
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

11/21/2025 12:35 PM • Pasithea Therapeutics reported positive pharmacokinetic data for its PAS-004 tablet in a Phase 1/1b trial for neurofibromatosis type 1 (NF1) patients, demonstrating linear dose-proportionality and improved tablet formulation characteristics.

KTTA - Reported favorable pharmacokinetic data showing linear dose response, improved tablet formulation, and potential for lower dosing with consistent exposure
#PAS-004 #MEK inhibitor #neurofibromatosis #pharmacokinetics #clinical trial
Read More
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against aTyr Pharma alleging false and misleading statements about the efficacy of their drug Efzofitimod during the period of January 16-September 12, 2025.

BHC - Carrying past baggage, but has diversified portfolio, stable cash flows, and potential for debt refinancing
ATYR - The lawsuit alleges the company made materially false statements about their drug's capabilities, potentially misleading investors and causing financial harm
#class action #securities lawsuit #investor alert #drug efficacy
Read More
FTNT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortinet, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
FTNT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortinet, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Fortinet, alleging the company made false and misleading statements about its FortiGate unit upgrades and projected business revenue between November 2024 and August 2025.

MLCO - Positioned to benefit from China's economic reopening, low P/S ratio, potential 20-30% revenue growth as tourism normalizes
FTNT - The lawsuit alleges the company made materially false statements about its business performance, product upgrades, and revenue projections, suggesting potential securities fraud and misrepresentation of company prospects
#class action #securities lawsuit #investor alert #false statements
Read More
MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Marex Group plc alleging false financial statements, undisclosed conflicts of interest, and misleading public statements during the period of May 16, 2024 to August 5, 2025.

MRX - The lawsuit alleges multiple serious financial irregularities including selling over-the-counter financial products to itself, creating conflicts of interest, and having unreliable financial statements that misled investors
#class action #securities fraud #financial misconduct #investor lawsuit
Read More
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Baxter International alleging systemic defects in their Novum LVP medical devices that potentially caused patient injuries and deaths, with claims of misleading investor communications.

BAX - The lawsuit alleges serious product defects in medical devices, potential patient harm, inadequate remedial actions, and misleading statements to investors, which significantly damages the company's reputation and potential financial standing
#class action #securities lawsuit #medical device #investor alert
Read More